title: TRPC3 mediates hyperexcitability and epileptiform activity in immature cortex and experimental cortical dysplasia.
abstract: Neuronal hyperexcitability plays an important role in epileptogenesis. Conditions of low extracellular calcium (Ca) or magnesium (Mg) can induce hyperexcitability and epileptiform activity with unclear mechanisms. Transient receptor potential canonical type 3 (TRPC3) channels play a pivotal role in neuronal excitability and are activated in low-Ca and/or low-Mg conditions to depolarize neurons. TRPC3 staining was highly enriched in immature, but very weak in mature, control cortex, whereas it was strong in dysplastic cortex at all ages. Depolarization and susceptibility to epileptiform activity increased with decreasing Ca and Mg. Combinations of low Ca and low Mg induced larger depolarization in pyramidal neurons and greater susceptibility to epileptiform activity in immature and dysplastic cortex than in mature and control cortex, respectively. Intracellular application of anti-TRPC3 antibody to block TRPC3 channels and bath application of the selective TRPC3 inhibitor Pyr3 greatly diminished depolarization in immature control and both immature and mature dysplastic cortex with strong TRPC3 expression. Epileptiform activity was initiated in low Ca and low Mg when synaptic activity was blocked, and Pyr3 completely suppressed this activity. In conclusion, TRPC3 primarily mediates low Ca- and low Mg-induced depolarization and epileptiform activity, and the enhanced expression of TRPC3 could make dysplastic and immature cortex more hyperexcitable and more susceptible to epileptiform activity.
authors.affiliation: Department of Neurosurgery and McKnight Brain Institute, University of Florida, Gainesville, Florida.
authors.forename: Fu-Wen
authors.initials: FW
authors.lastname: Zhou
authors.forename: Steven N
authors.initials: SN
authors.lastname: Roper
mesh_terms: D000016:Abnormalities, Radiation-Induced / Q000378:metabolism / Q000503:physiopathology*; D000200:Action Potentials; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002540:Cerebral Cortex / Q000196:embryology / Q000254:growth & development / Q000503:physiopathology; D019465:Craniofacial Abnormalities; D004828:Epilepsies, Partial / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D005260:Female; D005720:Gamma Rays; D008274:Magnesium / Q000378:metabolism; D008297:Male; D054220:Malformations of Cortical Development / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D011247:Pregnancy; D017966:Pyramidal Cells / Q000378:metabolism / Q000502:physiology; D011720:Pyrazoles / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D050052:TRPC Cation Channels / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
chemical_list: D011720:Pyrazoles; D050052:TRPC Cation Channels; C104603:TRPC3 cation channel; C559943:ethyl-1-(4-(2*3*3-trichloroacrylamide)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate; D008274:Magnesium; D002118:Calcium
keywords: epilepsy; epileptogenesis; low calcium; low magnesium; nonsynaptic